Skip to main content
Panacea Biotec Ltd. logo

Panacea Biotec Ltd. — Investor Relations & Filings

Ticker · PANACEABIO ISIN · INE922B01023 LEI · 3358001FA81ZQYDLO796 BSE.NS Manufacturing
Open in API
Filings indexed 793 across all filing types
Latest filing 2024-01-30 Regulatory Filings
Country IN India
Listing BSE.NS PANACEABIO

About Panacea Biotec Ltd.

https://www.panaceabiotec.com

Panacea Biotec Ltd. is a research-driven health management company specializing in the development, manufacturing, and marketing of vaccines, biopharmaceuticals, and pharmaceutical formulations. The organization focuses on therapeutic segments including organ transplantation, nephrology, oncology, diabetes, and pain management. Its vaccine portfolio supports global immunization initiatives, addressing diseases such as polio and hepatitis B through partnerships with international health agencies. The company operates integrated research and development centers and manufacturing facilities that adhere to international quality standards. Panacea Biotec emphasizes the creation of innovative drug delivery systems and complex generics to improve patient outcomes. Its operations are characterized by a commitment to biotechnology-led medical solutions and the production of affordable, high-quality therapeutic products for diverse global markets.

Recent filings

Filing Released Lang Actions
Board Meeting — PANACEA BIOTEC LIMITED has informed the Exchange about Board Meeting to be held on 13-Feb-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for th…
Regulatory Filings
2024-01-30 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges about an upcoming Board Meeting scheduled for February 13, 2024. The purpose of the meeting is to approve the Standalone and Consolidated Unaudited Financial Results for the quarter and nine months ended December 31, 2023. The document also mentions the closure of the trading window for insiders until February 15, 2024. The content is an announcement of a future event (board meeting and financial results approval) rather than the financial results report itself. The document length is short (2251 characters) and it does not contain actual financial data or detailed financial statements. Therefore, it is not an Interim/Quarterly Report (IR) but rather a Regulatory Filing (RNS) notifying the market about the board meeting and related compliance matters under SEBI regulations.
2024-01-30 English
Updates
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges and depositories regarding the details of shares dematerialized during December 2023. It references Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, and includes annexures with data on shares dematerialized and a certificate from the Registrar and Transfer Agent. The content is focused on share dematerialization data and compliance reporting rather than financial results, management changes, or other report types. It is a regulatory compliance filing providing specific shareholding and dematerialization information to stock exchanges and depositories. The document is not a financial report, earnings release, or management report, nor is it a voting result or capital change announcement. It fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance document that does not fit other specific categories.
2024-01-08 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended December 31, 2023. It is issued by the Registrar and Transfer Agent and addressed to stock exchanges. The document is short (1461 characters) and primarily serves as a certification of compliance rather than containing financial data or detailed report content. It does not contain financial statements or substantive financial analysis. Therefore, it fits the criteria for a Regulatory Filing (RNS) as it is a compliance certificate and not a full report or announcement of a report.
2024-01-08 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchanges about the closure of the trading window for insiders ahead of the announcement of unaudited financial results for the quarter and nine months ended December 31, 2023. It does not contain any financial data or results itself, nor does it include detailed financial statements or analysis. It is an announcement related to compliance with insider trading regulations and the timing of financial results disclosure. The document length is only 1755 characters, indicating it is a brief notice rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2023-12-26 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing the launch of a new vaccine product and the registration of a pharmaceutical product in Germany by Panacea Biotec. It is addressed to stock exchanges and includes contact details for company officials. The document is short (3051 characters) and primarily serves as a public announcement of corporate developments rather than a detailed financial report or regulatory filing. There is no financial data, no mention of annual or quarterly results, no voting results, no management changes, and no detailed governance or legal information. It is not a report but an announcement of a corporate event. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2023-12-14 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.